Community Trust & Investment Co. Has $13.76 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Community Trust & Investment Co. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 11.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,919 shares of the company’s stock after selling 4,744 shares during the period. Community Trust & Investment Co.’s holdings in HCA Healthcare were worth $13,761,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wedmont Private Capital lifted its holdings in shares of HCA Healthcare by 4.3% during the second quarter. Wedmont Private Capital now owns 3,476 shares of the company’s stock valued at $1,316,000 after acquiring an additional 144 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in HCA Healthcare by 3.8% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 25,421 shares of the company’s stock valued at $9,739,000 after acquiring an additional 925 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Pallas Capital Advisors LLC grew its holdings in shares of HCA Healthcare by 15.1% during the 2nd quarter. Pallas Capital Advisors LLC now owns 1,189 shares of the company’s stock worth $456,000 after purchasing an additional 156 shares in the last quarter. Finally, Baron Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter worth $236,000. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently commented on HCA. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 10th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Morgan Stanley lowered their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $403.17.

HCA Healthcare Stock Performance

NYSE:HCA opened at $398.75 on Thursday. The company has a fifty day simple moving average of $384.23 and a two-hundred day simple moving average of $364.54. The company has a market cap of $93.30 billion, a price-to-earnings ratio of 16.76, a price-to-earnings-growth ratio of 1.26 and a beta of 1.41. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.